Annual ROE
47.49%
+9.14%+23.83%
December 31, 2023
Summary
- As of February 7, 2025, BBIO annual return on equity is 47.49%, with the most recent change of +9.14% (+23.83%) on December 31, 2023.
- During the last 3 years, BBIO annual ROE has risen by +201.20% (+130.90%).
- BBIO annual ROE is now -26.52% below its all-time high of 64.63%, reached on December 31, 2021.
Performance
BBIO ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly ROE
37.14%
-1.45%-3.76%
September 30, 2024
Summary
- As of February 7, 2025, BBIO quarterly return on equity is 37.14%, with the most recent change of -1.45% (-3.76%) on September 30, 2024.
- Over the past year, BBIO quarterly ROE has dropped by -12.82% (-25.66%).
- BBIO quarterly ROE is now -88.04% below its all-time high of 310.55%, reached on June 30, 2021.
Performance
BBIO Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
ROE Formula
ROE = Net Income
Shareholders Equity ✕ 100%
Shareholders Equity ✕ 100%
BBIO ROE Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +23.8% | -25.7% |
| 3 y3 years | +130.9% | -25.7% |
| 5 y5 years | +214.4% | -25.7% |
BBIO ROE Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -26.5% | +23.8% | -59.2% | +1.5% |
| 5 y | 5-year | -26.5% | +130.9% | -88.0% | +110.3% |
| alltime | all time | -26.5% | +130.9% | -88.0% | +110.3% |
BridgeBio Pharma ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | 37.14%(-3.8%) |
| Jun 2024 | - | 38.59%(-10.9%) |
| Mar 2024 | - | 43.29%(-13.4%) |
| Dec 2023 | 47.49%(+23.8%) | 49.96%(+2.9%) |
| Sep 2023 | - | 48.53%(+5.5%) |
| Jun 2023 | - | 46.02%(+25.7%) |
| Mar 2023 | - | 36.60%(-15.2%) |
| Dec 2022 | 38.35%(-40.7%) | 43.16%(-10.4%) |
| Sep 2022 | - | 48.17%(-13.0%) |
| Jun 2022 | - | 55.36%(-27.5%) |
| Mar 2022 | - | 76.41%(-16.0%) |
| Dec 2021 | 64.63% | 90.97%(-34.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2021 | - | 138.59%(-55.4%) |
| Jun 2021 | - | 310.55%(-185.7%) |
| Mar 2021 | - | -362.20%(+155.4%) |
| Dec 2020 | -153.71%(+151.7%) | -141.84%(+40.9%) |
| Sep 2020 | - | -100.64%(-12.1%) |
| Jun 2020 | - | -114.50%(-8.3%) |
| Mar 2020 | - | -124.89%(-3.6%) |
| Dec 2019 | -61.07%(+47.1%) | -129.61%(+2.0%) |
| Sep 2019 | - | -127.08%(-46.1%) |
| Jun 2019 | - | -235.78%(+323.7%) |
| Mar 2019 | - | -55.65%(+34.0%) |
| Dec 2018 | -41.52%(-178.8%) | -41.52% |
| Dec 2017 | 52.68% | - |
FAQ
- What is BridgeBio Pharma annual return on equity?
- What is the all time high annual ROE for BridgeBio Pharma?
- What is BridgeBio Pharma annual ROE year-on-year change?
- What is BridgeBio Pharma quarterly return on equity?
- What is the all time high quarterly ROE for BridgeBio Pharma?
- What is BridgeBio Pharma quarterly ROE year-on-year change?
What is BridgeBio Pharma annual return on equity?
The current annual ROE of BBIO is 47.49%
What is the all time high annual ROE for BridgeBio Pharma?
BridgeBio Pharma all-time high annual return on equity is 64.63%
What is BridgeBio Pharma annual ROE year-on-year change?
Over the past year, BBIO annual return on equity has changed by +9.14% (+23.83%)
What is BridgeBio Pharma quarterly return on equity?
The current quarterly ROE of BBIO is 37.14%
What is the all time high quarterly ROE for BridgeBio Pharma?
BridgeBio Pharma all-time high quarterly return on equity is 310.55%
What is BridgeBio Pharma quarterly ROE year-on-year change?
Over the past year, BBIO quarterly return on equity has changed by -12.82% (-25.66%)